VEGFA and hyperlipidemia: Gender, presence or absence of HT, hyperlipidemia, oral hypoglycemic agent use, oral hyperlipidemia, oral anticoagulant use, oral antiplatelet agent use, preoperative logMAR BCVA, axial length, smoking history, BMI, dialysis, the presence or absence of preoperative high systolic blood pressure, fasting blood pressure, preoperative anti-VEGF vitreous injection, and preoperative PRP were compared between the two groups, and no significant differences were observed in any parameter (p > 0.05).